AI assistant
Sending…
Alaunos Therapeutics, Inc. — Director's Dealing 2012
Jan 4, 2012
35407_dirs_2012-01-04_649b3c13-e03c-4f7f-9f45-499ef8d7cebf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ZIOPHARM ONCOLOGY INC (ZIOP)
CIK: 0001107421
Period of Report: 2011-12-30
Reporting Person: BELBEL CAESAR J (EVP, CLO, and Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-12-30 | Common Stock | A | 21578 | $0.00 | Acquired | 21578 | Direct |
Footnotes
F1: 7,193 shares vest on each of 12/30/2012 and 12/30/2013; and 7,192 shares vest on 12/30/2014.
More from Alaunos Therapeutics, Inc.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 15
Delisting Announcement
2026
Apr 15
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Jan 15
Director's Dealing
2026
Jan 15
Director's Dealing
2026
Jan 15
Regulatory Filings
2026
Jan 8